Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

- Parkinson's Disease
- Completed

Study Title: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

Teva Identifier: TVP1012-PK-10002

ClinicalTrials.gov Identifier: NCT01879748

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 20 Years to 50 Years

Trial Duration: 06/01/2013 - 11/01/2013

Phase: Phase 1

Study Type

Interventional